chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a patient who on 8/5/96 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed mild breakthrough with less than 50 lesions. It was noted that the patient was part of 7 children reported, 4 males and 3 female, some of which are siblings who were vaccinated with varicella virus vaccine live. Unspecified medical attention was sought. There was no product quality complaint involved. The reporter also mentioned six other patients who were vaccinated with varicella virus vaccine live and experienced similar reactions. Additional information has been requested.
W/in 36 hrs of vax pt devel h/a, meningismus, photophobia, D, severe vomiting, fever 100.5 to 101F.  Sx persisted for 24 nrs.
Severe burning & itching & dollar size hot-spot, within minutes. Then generalized rash & swelling spreading to armpit & to elbow (Left arm) (Pacemaker implant - two to three inches from rash & swelling) returned to see Dr - 12-17-2010. He had not seen a reaction like mine. He suggested BENADRYL (po) and Topical Cortisone. 12-28-2010 still have dollar size red itching spot at injection site. Time course 3 wks to date.
Information has been received from a registered nurse (R.N.) concerning a 22 year old female (a relative of another employee) who was vaccinated with a third dose of GARDASIL.  Subsequently the patient died.  The cause of death was unknown.  Additional information has been requested.
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that the patient may have received improperly stored GARDASIL (lot #, expiry not reported) between 15-AUG-2013 to present 06-SEP-2013 (exact dates of administration unspecified). No adverse event reported. Additional information is not expected.
This spontaneous report as received from a physician refers to a 64 years old female patient. The patient was vaccinated with a dose of PNEUMOVAX 23 (Lot number reported as H013581, expiration date unspecified) 0.5 ml in her left arm (route not reported) on 25-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. At an unspecified time interval, in October 2012, the patient developed redness, swelling, pain and patchy ecchymosis on her left arm. The physician stated that the patient went to an unspecified emergency department and received unspecified antibiotics intravenously. The physician did not specify if the patient was hospitalized, but she said that the patient was very unhappy and that her condition on her left arm was limiting her daily functioning. The physician also stated that the patient's condition did not improve in response to the intravenous antibiotics and that the patient was in her practice and was very angry. The relatedness for the events was not reported for PNEUMOVAX 23. Redness, swelling, pain and patchy ecchymosis on her left arm, unhappy, condition on left arm limiting her daily functioning and angry were considered to be disabling by the reporting physician. Additional information has been requested.
Felt sick after one day; Vaccine given after 48 hours of a punctured vial; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine given after 48 hours of a punctured vial) and MALAISE (Felt sick after one day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine given after 48 hours of a punctured vial). On an unknown date, the patient experienced MALAISE (Felt sick after one day). At the time of the report, PRODUCT ADMINISTRATION ERROR (Vaccine given after 48 hours of a punctured vial) and MALAISE (Felt sick after one day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant Medications were not provided by the reporter. Treatment Information was not provided by the reporter.   This case was linked to MOD-2021-077668, US-MODERNATX, INC.-MOD-2021-078047, US-MODERNATX, INC.-MOD-2021-078057 (E2B Linked Report).; Sender's Comments:  MOD-2021-077668: US-MODERNATX, INC.-MOD-2021-078057: US-MODERNATX, INC.-MOD-2021-078047:
soreness at administration site; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE DISCOMFORT (soreness at administration site) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOMFORT (soreness at administration site) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE DISCOMFORT (soreness at administration site) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Patient died approximately 28 hours after Hepatitis B injection. Manner of death, natural, Cause of Death-- SIDS Per F/U 3/27/02: final autopsy dx: Pulmonary edema, anterior thymic petechiae, reactive chronic inflammation; bronchioles, epiglottis. Lungs were heavy for agevand exuded copious fluid. She was found to be blue and unresponsive by her father at approx. 1:50 pm on 9/28/01, after he was awakened by a telephone call. At that time, he called 911 and attempted CPR while waiting for help to arrive. When EMS personnel attempted intubation, copious vomitus exuded from the tube and oral cavity. ER personnel continued ACLS protocols without success.
mistakenly administered Menquadfi to a 6 year old with no reported adverse event; Initial information received on 20-Mar-2023 regarding an unsolicited valid non-serious case received from a nurse practitioner.  This case involves a 6 years old and unknown gender patient to whom meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] was administered mistakenly with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On 10-Mar-2023, the patient received an 0.5 ml (milliliter) of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, solution for injection (Strength = standard) (With unknown route, lot number, expiration and at unknown administration site) for immunization.  On 10-Mar-2023, reporter reported that mistakenly, menquadfi was administered to a 6-year-old with no reported adverse event (wrong product administered) (latency: same day).  It was also reported that Nurse practitioner reports that the 6-year-old patient has no special indications to receive MENQUADFI.  No lab data were reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for an event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient states she is itchy and requests IM Benadryl injection, patient is visibly itchy and lagging. Patient given therapy then monitored for 30 minutes prior to release from observation.
Nosebleed, chest tightness, anxious, dizzy. Knot (baseball size) on Rt arm.
erythema, ecchymosis, pain & edema @ inject are reported in a pt who recvd 1 dose of flu vax; above sx occurred 12 hrs p/flu given & resolved w/in 48 hrs;
Patient c/o flu like symptoms joint pain, fatigue and hypersensitivity in hand and feet 3 days after anthrax vaccination; lasted 5 days skin on fingers, toes, heels peeled off.
Within 10 minutes after vaccination was given, pt developed a hive reaction that started at the injection site and spread to top of chest and lower neck, continued to spread up 45 minute post vaccine.  Pt was evaluated by  NP - BP 134/89, pulse 90.  (2) 25mg  oral benedryl were administered & 1 claritin tab.  At90 minute post vaccination, hives rash had resolved.  No other S/sx were noted.
This spontaneous report was received from a medical assistant refers to unknown number of patients of unknown age and gender. On unknown date (between November 2013 and July 2013), the patients were vaccinated with GARDASIL (dose, route and lot# were not reported) that had been improperly stored. No adverse effects reported. This is one of 6 reports received from the same reporter. Additional information has been requested.
Pfizer covid vaccine expired (in fridge BUD: 11/29/21)  0.3 mL given to patient.   The error was noticed 1 hr later.  Clinic leadership notified. The patient was retuning with her card, as she had forgotten it.  She has no symptoms and no adverse reaction. Pt returned.  The error was explained, the patient was offered a valid dose of Pfizer covid 19 vaccine.  She accepted.
Nearly inconsolable crying for most of a six hour period that began about an hour after receiving DTaP.
Information has been received from a certified medical assistant concerning a 12-year-old female with an allergy to Zithromax and no pertinent medical history who on 12-AUG-2000 was vaccinated subcutaneous with 0.5 mL dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included Triaminic Syrup and ibuprofen. On 02-SEP-2007, the patient developed varicella and has about 10-20 lesions. The patient sought medical attention via an office visit. No diagnostic labs were performed. At the time of the report the patient status is recovering. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested. Additional information has been requested.
Left eyelid itched; Left eyelid hurt; Left eyelid swollen; This spontaneous case was reported by a consumer and describes the occurrence of EYELIDS PRURITUS (Left eyelid itched), EYELID PAIN (Left eyelid hurt) and SWELLING OF EYELID (Left eyelid swollen) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, the patient experienced EYELIDS PRURITUS (Left eyelid itched), EYELID PAIN (Left eyelid hurt) and SWELLING OF EYELID (Left eyelid swollen). At the time of the report, EYELIDS PRURITUS (Left eyelid itched), EYELID PAIN (Left eyelid hurt) and SWELLING OF EYELID (Left eyelid swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment medications were reported Patient reported that symptoms were lasted for 24 hours.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild
Pt received the spikevax vaccine on 11/10 and woke up on 11/12 with a raised rash on her trunk. She is taking benadryl to help with reaction. She also had just started a new medication (atomoxetine) the day before. It may be possible the reaction has been caused by that.  I informed her to call her doctor in the morning.
left leg, knee, foot inflammation.  left knee would not support weight without support device.  Lasted 6 weeks.
This spontaneous report was received from a medical assistant concerning an adult patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. The medical assistance reported that on an unknown date, the patient was vaccinated with one dose of pediatric RECOMBIVAX HB (dose, route, lot number and expiration date were not reported)  and one dose of pediatric VAQTA (dose, route, lot number and expiration date were not reported), both for prophylaxis. No adverse effects were reported. Additional information has been requested.
arm swelled up; arm broke out in rash; fever; belly cramping; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (belly cramping), PERIPHERAL SWELLING (arm swelled up), RASH (arm broke out in rash) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced ABDOMINAL PAIN (belly cramping). On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelled up), RASH (arm broke out in rash) and PYREXIA (fever). At the time of the report, ABDOMINAL PAIN (belly cramping) outcome was unknown, PERIPHERAL SWELLING (arm swelled up) and RASH (arm broke out in rash) had not resolved and PYREXIA (fever) had resolved.            She also had a fever and felt bad for 24 hours Patient used Tylenol to treat fever.
Information has been received from a licensed practical nurse referring to unspecified patients. On an unknown date unspecified number of unspecified patients were vaccinated with doses of improperly stored ZOSTAVAX, subcutaneously. No adverse effect reported. Additional information has been requested.
pt recv vax 7DEC93 & JAN devel pneumonia which led to emphysema;cult was positive for pneumococcus (type unk)
3 days post vaccine, noticed pain in left armpit area 2 weeks post vaccine, noticed palpable cord in the breast, tenderness with arm movement and palptation
Pt. in for imms. as below, gave imms pt became blotchy on (B)LE, trunk, face, neck, back (L)UE. Also produced petechial rash on neck and top of shoulder area. Pt was checked by Dr, given liquid oral BENADRYL 18 mL watched for about 40 min - rash dissipated pt went home with BENADRYL q 6 hrs.
Horrible joint pain I couldn't move; Diarrhea; vomiting; headache; chills; low grade fever; sweating; my right hand got so inflamed that it looked weird; This is a spontaneous report from a contactable consumer (patient). A 43-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 24Feb2021 10:15 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunisation. Medical history included Multiple epificial dysplasia. Known allergies: Penicillin, latex. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 03Feb2021, 09:00 AM (Batch/Lot Number: EL9269) as SINGLE DOSE for covid-19 immunisation. No Other vaccine in four weeks. No Covid prior vaccination. No covid tested post vaccination. On 24Feb2021, 15.00, the patient had horrible joint pain she couldn't move, her right hand got so inflamed that it looked weird, she had diarrhea, vomiting, headache, chills, low grade fever, sweating. She has multiple epiphyseal dysplasia, she was thinking that's why her joints had such a reaction. It lasted less than 48 hrs. No treatment received. Outcome of the events was recovered in Feb2021.
mild swelling & arm pain followed by red arm, hand swelling & pain @ 48hr;
Purple indurated 9mm x 9mm, swollen pink R upper thigh injection site. Motrin q 6 prn.
pt exp immed knot @ the site of the inj;had become larger & itchy by 2 days post vax;pt upper arm became more swollen & more red over the next wk;pt had an office visit 9 days post vax by which time pt was feeling better & exp no soreness
Information has been received from a pharmacist concerning an adult female client with an unknown previous vaccination history who was Pneumovax 23 (lot unknown). Subsequently the client experienced a "severe local site reaction" and "induration the size of a softball". It was reported that the client sought unspecified medical attention. No other information was available at the time of call. There was no product quality complaint involved. It was reported that two other adult female experienced local site reactions and induration after administration of Pneumovax 23 (lot unknown) (WAES0412USA01332 and WAES0502USA00004). Additional information has been requested.
Following my second dose of Moderna Covid 19 vaccine on 2/13/21 I experienced a significant reaction to the second dose: My temperature rose to 102 with headache and arthralgia throughout body that prevented sleep. I was in bed for more than 24 hours due to lightheaded/dizzy/nausea when standing. I fell once when getting back into bed due to loss of balance. Severe symptoms started 15 hours after receiving the dose and lasted approximately 36 hours post dose when my temperature then returned to normal. The next 1-2 days, while I no longer had a fever and symptoms were improved. I was still fatigued and did not feel fully recovered. Treatment during the severe symptoms included rest, icepack to head, Tylenol or Ibuprofen slightly decreased temperature for a brief periods. I informed my physician's office Dr, of the above reaction and was told to file a VAERS report.
After my first vaccine, I started to have breakthrough bleeding, having my menstrual cycle every two weeks, first one lasting eight days straight.  I went to se my gynecologist who performed an Ultrasound but could not find anything wrong. Since my first vaccine, my menstrual cycle has been out of sync. I am actually starting a week and a half earlier for my menstrual cycle and this really concerns me since I am planning for embryo in the future.
Exposed to chicken pox at day care. On 04/18/2002 itchy, spots on arms and face, headache and cough.  10-12 red papules.  Some with crusting.
Then got shot too early, got it another 2 weeks; Broke 2 back teeth; Broke 2 back teeth the pain was so bad; Then got shot too early, got it another 2 weeks; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine and an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Then got shot too early, got it another 2 weeks), tooth fracture (Verbatim: Broke 2 back teeth), toothache (Verbatim: Broke 2 back teeth the pain was so bad) and drug dose administration interval too short (Verbatim: Then got shot too early, got it another 2 weeks). The outcome of the shingles was not recovered/not resolved and the outcome of the tooth fracture and toothache were not reported and the outcome of the drug dose administration interval too short was unknown.   It was unknown if the reporter considered the shingles, tooth fracture and toothache to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the shingles, tooth fracture and toothache to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 03-MAR-2023 The case was received from the patient via interactive digital media. The patient stated that 7 weeks of purred hell he/she got Shingles shot too early, got shingles in another 2 weeks. The patient broke 2 back teeth the pain was so bad. The patient stated that now year and half he/she still felt like 10,000 ants crawling on him/her at times. The patient stated that it was like never going away. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
10 minutes after vaccination patient stated that her left arm (injection arm) felt heavy and that her left jaw and left ear felt hot, numb, congested and swollen.  Patient was having no problems breathing, no wheezing, no problem swallowing so we did not administer epinephrine.  We called 911 in case symptoms escalated at 12:55pm.  EMS was present in 5 minutes.  EMS monitored patient but left store at 1:23 because patient did not want to go to emergency room and her symptoms were not worsening.  Patient stated that her husband was home, very close by, and that he was a nurse practitioner and that he was going to monitor her at home.  Patient purchased Benadryl liquid and Claritin tablets.
Alopecia shortly after 2nd Primary dose/My Hair Is Gone after 2nd vaccine/Everyone is laughing at me post alopecia after 2nd vaccine; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (Alopecia shortly after 2nd Primary dose/My Hair Is Gone after 2nd vaccine/Everyone is laughing at me post alopecia after 2nd vaccine) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ALOPECIA (Alopecia shortly after 2nd Primary dose/My Hair Is Gone after 2nd vaccine/Everyone is laughing at me post alopecia after 2nd vaccine). At the time of the report, ALOPECIA (Alopecia shortly after 2nd Primary dose/My Hair Is Gone after 2nd vaccine/Everyone is laughing at me post alopecia after 2nd vaccine) outcome was unknown.            No concomitant medications were reported.  Adult patient was calling to file a complaint. He stated that he received 2 doses of Moderna COVID-19 vaccine in 2021. He stated that shortly after 2nd dose, he started having alopecia profanity and cursing Moderna employees. He stated that he has not wasted his time going to a doctor. patients hair was gone and everyone was laughing at patient, and patient can not even sue Moderna.  No treatment medications were reported.   Reporter did not allow further contact
This patient received three vaccinations of Lymerix (Lyme) between 1999 and 2000. At the end of 1999 developed shoulder and neck pains. Diagnosed with osteoarthritis?
Patient describes waking up the next morning and tried to stretch and couldn't move her arm.  She states her arm is bruised  and cant lift her arm and it radiates up her shoulder.  arm has been hot and cold.  She is wearing a brace.   She did bleed after receiving shot.